Claforan New Zealand - English - Medsafe (Medicines Safety Authority)

claforan

sanofi-aventis new zealand limited - cefotaxime sodium 1.05 g;  ;   - powder for injection - 1 g - active: cefotaxime sodium 1.05 g    

Claforan New Zealand - English - Medsafe (Medicines Safety Authority)

claforan

sanofi-aventis new zealand limited - cefotaxime sodium 2.1 g;  ;   - powder for injection - 2 g - active: cefotaxime sodium 2.1 g    

Claforan New Zealand - English - Medsafe (Medicines Safety Authority)

claforan

sanofi-aventis new zealand limited - cefotaxime sodium 525mg;  ;   - powder for injection - 500 mg - active: cefotaxime sodium 525mg    

CLAFORAN Israel - English - Ministry of Health

claforan

sanofi - aventis israel ltd - cefotaxime as sodium 1 g - powder for solution for inj/inf - cefotaxime - severe infections caused by cefotaxime - sensitive pathogens : infections of the respiratory tract of the kidneys and urinary tract of the skin and soft tissues of the bones and joints of the genital organs including gonorrhoea and of the abdominal region. sepsis endocarditis meningitis. for preoperative prophylaxis in patients who are at increased risk from infection. for the prophylaxis of infections in patients with reduced resistance.